Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
Masiá et al., EBioMedicine, doi:10.1016/j.ebiom.2020.102999
https://c19early.org/masia.html